GHK-Cu is a copper-bound tripeptide-glycyl-L-histidyl-L-lysine chelated to a single Cu ion-extensively studied for its role in tissue repair, collagen production, wound healing, and regenerative biology
The goal is to achieve even greater weight loss compared to GLP-1 monotherapy
Identification of the major intestinal fatty acid transport protein
Facility registration, cGMP language, a Supplement Facts panel, or the standard DSHEA disclaimer does not mean FDA validated the ingredient, delivery system, safety, or claims
Novo Nordisk is looking to increase access to these drugs for people without insurance coverage -- and perhaps dominate that market over the more expensive tirzepatide -- while undercutting the efforts of compounding pharmacies